Hamilton K, Tein M, Glazier J, Mawer E B, Berry J L, Balment R J, Boyd R D, Garland H O, Sibley C P
School of Biological Sciences, Academic Unit of Child Health, University of Manchester, Manchester M13 9PT, UK.
J Endocrinol. 2000 Jan;164(1):67-76. doi: 10.1677/joe.0.1640067.
Offspring of rats with diabetes mellitus are at risk of reduced calcium and bone mineral content. Altered expression of the maternal calcium binding proteins, calbindin-D(9K) and calbindin-D(28K), which are involved in renal and placental calcium transport, may underlie these problems.We have investigated the effect of diabetes on circulating concentrations of regulatory hormones with respect to calbindin-D mRNA concentrations. Three rat groups were studied; control (CP), streptozotocin-induced diabetic (DP), and insulin-treated diabetic (DPI) pregnant rats. Calbindin-D(9K) and calbindin-D(28K) mRNA abundance in placenta and maternal kidney were measured at days 7, 15, 18 and 21 of gestation, together with serum or plasma concentrations of 1,25 dihydroxyvitamin D(3) (1, 25(OH)(2)D(3)), parathyroid hormone (PTH), PTH-related protein (PTHrP), calcitonin, oestradiol and IGF-I. An increase in placental calbindin-D(9K) mRNA abundance between days 18 and 21 in CP and DPI rats was severely blunted in the DP rats. In contrast, renal calbindin-D(28K) mRNA abundance was greater at days 7, 15 and 18 in DP compared with CP rats, as was calbindin-D(9K) at day 18. Calcitonin concentrations showed no differences between the groups, and both PTH and IGF-I were reduced over the first half of gestation, unlike the calbindins. In contrast, the concentrations of PTHrP and 1,25(OH)(2)D(3) were reduced at term in the DP group compared with the other two groups. Plasma oestradiol concentrations were lower in DP than in CP rats at days 7, 15 and 18, and most striking was the absence in DP rats of the peak of oestradiol seen at day 18 in CP rats. Despite the similarity between changes in placental calbindin mRNA and 1,25(OH)(2)D(3), previous work has shown placental calbindin-D(9K) regulation to be vitamin-D-independent. These studies produce suggestive evidence, therefore, that PTHrP and oestradiol may be involved in the altered calbindin-D expression by kidney and placenta in rat diabetic pregnancy.
糖尿病大鼠的后代有钙和骨矿物质含量降低的风险。参与肾脏和胎盘钙转运的母体钙结合蛋白钙结合蛋白-D(9K)和钙结合蛋白-D(28K)表达的改变可能是这些问题的基础。我们研究了糖尿病对与钙结合蛋白-D mRNA浓度相关的调节激素循环浓度的影响。研究了三组大鼠;对照组(CP)、链脲佐菌素诱导的糖尿病组(DP)和胰岛素治疗的糖尿病组(DPI)怀孕大鼠。在妊娠第7、15、18和21天测量胎盘和母体肾脏中钙结合蛋白-D(9K)和钙结合蛋白-D(28K)mRNA的丰度,以及血清或血浆中1,25-二羟基维生素D(3)(1,25(OH)(2)D(3))、甲状旁腺激素(PTH)、PTH相关蛋白(PTHrP)、降钙素、雌二醇和IGF-I的浓度。CP和DPI大鼠在第18至21天胎盘钙结合蛋白-D(9K)mRNA丰度的增加在DP大鼠中严重减弱。相反,与CP大鼠相比,DP大鼠在第7、15和18天肾脏钙结合蛋白-D(28K)mRNA丰度更高,第18天钙结合蛋白-D(9K)也是如此。降钙素浓度在各组之间没有差异,与钙结合蛋白不同,PTH和IGF-I在妊娠前半期均降低。相反,与其他两组相比,DP组足月时PTHrP和1,25(OH)(2)D(3)的浓度降低。在第7、15和18天,DP大鼠的血浆雌二醇浓度低于CP大鼠,最显著的是DP大鼠在第18天没有出现CP大鼠中所见的雌二醇峰值。尽管胎盘钙结合蛋白mRNA和1,25(OH)(2)D(3)的变化相似,但先前的研究表明胎盘钙结合蛋白-D(9K)的调节与维生素D无关。因此,这些研究提供了提示性证据,表明PTHrP和雌二醇可能参与了大鼠糖尿病妊娠中肾脏和胎盘钙结合蛋白-D表达的改变。